Cargando…
Non-Invasive Prediction of Hepatic Fibrosis in Patients With Chronic HCV Based on the Routine Pre-Treatment Workup
BACKGROUND: Hepatic fibrosis is an inclusion indicator for treatment and a major independent predictor of treatment response in patients with chronic hepatitis C. Liver biopsy, considered as the “gold standard” for evaluating liver fibrosis, has carried some drawbacks. Currently used noninvasive pre...
Autores principales: | Khairy, Marwa, Abdel-Rahman, Mahassen, El-Raziky, Maissa, El-Akel, Wafaa, Zayed, Naglaa, Khatab, Hany, Esmat, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549416/ https://www.ncbi.nlm.nih.gov/pubmed/23346149 http://dx.doi.org/10.5812/hepatmon.6718 |
Ejemplares similares
-
The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study
por: El Raziky, Maissa, et al.
Publicado: (2013) -
The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis
por: Khairy, Marwa, et al.
Publicado: (2013) -
Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4
por: Shaker, Olfat, et al.
Publicado: (2013) -
Egy-Score as a Noninvasive Score for the Assessment of Hepatic Fibrosis in Chronic Hepatitis C: A Preliminary Approach
por: Alboraie, Mohamed, et al.
Publicado: (2014) -
Increased incidence of cytomegalovirus coinfection in HCV-infected patients with late liver fibrosis is associated with dysregulation of JAK-STAT pathway
por: Ibrahim, Marwa K., et al.
Publicado: (2017)